Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion type Assertion NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_head.
- NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion description "[Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel therapeutic agents for inflammatory disorders including nonalcoholic fatty liver disease (NAFLD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_provenance.
- NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion evidence source_evidence_literature NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_provenance.
- NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion SIO_000772 26297911 NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_provenance.
- NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion wasDerivedFrom befree-2016 NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_provenance.
- NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_assertion wasGeneratedBy ECO_0000203 NP1293009.RAG6dDUYWf20HGpvCouLl3EeZcotTK32SLk0SKBh_F6xc130_provenance.